Barclays: Chinese equity fundamentals remain weak, but crowded shorts offer an opportunity for a sharp rally

Why discuss upside opportunities while remaining cautious on fundamentals?

As of 20 October, the date of the data used in the report, FXI, which tracks Chinese equities, had fallen approximately 14% year to date, while the S&P 500 had risen approximately 13% over the same period. Barclays’ base case remains that China avoids a hard landing but experiences sluggish growth: property weakness, soft household demand and slower credit creation offset policy support and strength in manufacturing and technology.
Accordingly, if current conditions persist, the bank still sees downside for Chinese equities. The starting point for the short-term bullish trade is that positioning and option pricing create another path: even without a wholesale change in the growth outlook, concentrated short covering could drive a sharp rise in share prices.

Barclays’ positioning analysis shows that CTA strategies’ short positions in Chinese equities are near their limits, leaving limited room for further selling and making position adjustments more likely to involve short covering. If a rise triggers positions to be closed, demand to buy back shares could amplify the rebound.
Meanwhile, FXI and ASHR, which tracks A-shares, rank toward the cheaper end of the bank’s volatility screen. Here, “cheap” refers to option volatility pricing: the screen compares where measures including implied volatility, its premium over realized volatility and the term structure stand relative to the past two years.
The bank also cites FXI’s steep skew structure as favorable for constructing an upside trade. Its rationale is to use both crowded short positions and relative option pricing, rather than infer a rebound solely from the fact that share prices have fallen.

Barclays proposes buying two FXI call options expiring on 27 November 2026 with a strike price of 35 dollars, while selling one call option expiring on the same day with a strike price of 34 dollars. At an FXI reference price of 32.9 dollars, the net cost is approximately 0.20 dollars per share, equivalent to 61 basis points of the reference price.
The low net outlay comes from the premium received for selling the lower-strike option, which also creates losses at intermediate prices. Under the terms above, if FXI is exactly 35 dollars at expiry, the sold option loses 1 dollars and neither purchased option has any value at expiry; including the initial cost, the net loss is approximately 1.20 dollars per share.
Only after the share price exceeds 35 dollars at expiry does the position begin to improve with further gains; the break-even price is approximately 36.2 dollars. The report puts the corresponding gain at 9.9%, and since the COVID pandemic, FXI has historically reached that threshold over one month approximately 11% of the time. This trade bets on the magnitude of a sharp rally; a modest rebound is not enough.

The 27 November expiry covers a concentrated set of catalysts: the Caixin manufacturing PMI on 2 November; retail sales, industrial production, property and fixed-asset investment data around 15 November; Tencent’s earnings on 18 November; and Alibaba’s earnings expected on 25 November.
These events provide a window for repricing and short covering; for the trade to be profitable, the rise must occur before expiry and be large enough. Weak fundamentals remain the main constraint noted by Barclays, and crowded short positions have not in themselves changed its base-case growth outlook.